The arena of digital health and FDA regulations that apply to apps, wearables and software, including artificial intelligence (AI) and machine learning (ML) continue to evolve in the United States. See select articles and tweets for latest news one these topics here.
IBM (NYSE: IBM) announced yesterday that Watson will gain the ability to “see” by uniting Watson’s advanced image analytics and cloud-based cognitive capabilities with data and images obtained from Merge Healthcare (NASDAQ: MRGE). The announced merger is valued…Read More
The dust has settled after the successful IPO of FitbitĀ (NYSE: FIT), who can accurately be described as the world’s largest wearables maker. Fitbit raised approximately $732 million from a $20/share pricing (valuing the company at $4.1 billion) and…Read More
The FDA issued final guidances applicable to digital health products on mobile medical applications (MMA) and medical device data systems (MDDS) in February 2015 and a draft guidance on general wellness products (GWP) in January 2015. The MMA…Read More